Pembrolizumab and Tamoxifen With or Without Vorinostat for the Treatment of Estrogen Receptor Positive Breast Cancer

NCT04190056 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Change in practice patterns

Conditions

Anatomic Stage IV Breast Cancer AJCC v8
Prognostic Stage IV Breast Cancer AJCC v8

Interventions

BIOLOGICAL: Pembrolizumab
DRUG: Tamoxifen
DRUG: Vorinostat

Sponsor

University of California, San Francisco

Collaborators

[object Object]